4. REGULATORY IMPACT: International Treaty Obligations: Rescheduling marijuana to Schedule III will allow the United States to continue meeting its international treaty obligations under the Single Convention on Narcotic Drugs and the Convention on Psychotropic Substances with additional regulatory controls as needed Economic Considerations: Rescheduling may have significant economic impacts, including effects on federal taxes, research, and development investments in the pharmaceutical industry. The DEA is seeking comments on these potential economic impacts as part of the rulemaking process •
CONCLUSION
The proposed rulemaking to reschedule marijuana to Schedule III is based on a comprehensive review of scientific, medical, and epidemiological data by HHS. The recommendation acknowledges marijuana’s lower potential for abuse and dependence compared to Schedule I and II substances and its recognized medical use in the United States. The DEA is inviting public comments to further inform this rulemaking process
PAGE 7
Made with FlippingBook - professional solution for displaying marketing and sales documents online